723 related articles for article (PubMed ID: 16684424)
21. Folate and cobalamin synergistically decrease the risk of high plasma homocysteine in a nonsupplemented elderly institutionalized population.
Huerta JM; González S; Vigil E; Prada M; San Martín J; Fernández S; Patterson AM; Lasheras C
Clin Biochem; 2004 Oct; 37(10):904-10. PubMed ID: 15369722
[TBL] [Abstract][Full Text] [Related]
22. Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects.
Araki R; Maruyama C; Igarashi S; Yoshida M; Maruyama T; Satoh T; Yoshida M; Umegaki K
Eur J Clin Nutr; 2006 May; 60(5):573-9. PubMed ID: 16391577
[TBL] [Abstract][Full Text] [Related]
23. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
[TBL] [Abstract][Full Text] [Related]
24. Effects of multivitamins and low-dose folic acid supplements on flow-mediated vasodilation and plasma homocysteine levels in older adults.
Carlsson CM; Pharo LM; Aeschlimann SE; Mitchell C; Underbakke G; Stein JH
Am Heart J; 2004 Sep; 148(3):E11. PubMed ID: 15389247
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
Verhoef P; Meleady R; Daly LE; Graham IM; Robinson K; Boers GH
Eur Heart J; 1999 Sep; 20(17):1234-44. PubMed ID: 10454975
[TBL] [Abstract][Full Text] [Related]
26. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
[TBL] [Abstract][Full Text] [Related]
27. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
29. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
30. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.
Woolf K; Manore MM
J Am Diet Assoc; 2008 Mar; 108(3):443-53; discussion 454. PubMed ID: 18313425
[TBL] [Abstract][Full Text] [Related]
31. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
32. Is plasma homocysteine a modifiable risk factor for stroke?
Hankey GJ
Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
[TBL] [Abstract][Full Text] [Related]
33. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia.
Levine J; Stahl Z; Sela BA; Ruderman V; Shumaico O; Babushkin I; Osher Y; Bersudsky Y; Belmaker RH
Biol Psychiatry; 2006 Aug; 60(3):265-9. PubMed ID: 16412989
[TBL] [Abstract][Full Text] [Related]
34. Effect of fortified spread on homocysteine concentration in apparently healthy volunteers.
van Vliet T; Jacobs RG; de Deckere E; van den Berg H; de Bree A; van der Put NM
Eur J Clin Nutr; 2007 Jun; 61(6):769-78. PubMed ID: 17151589
[TBL] [Abstract][Full Text] [Related]
35. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
[TBL] [Abstract][Full Text] [Related]
36. Folate, vitamin B12 and homocysteine status in women of childbearing age: baseline data of folic acid wheat flour fortification in Iran.
Abdollahi Z; Elmadfa I; Djazayeri A; Sadeghian S; Freisling H; Mazandarani FS; Mohamed K
Ann Nutr Metab; 2008; 53(2):143-50. PubMed ID: 18997463
[TBL] [Abstract][Full Text] [Related]
37. Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study.
Romagnuolo J; Fedorak RN; Dias VC; Bamforth F; Teltscher M
Am J Gastroenterol; 2001 Jul; 96(7):2143-9. PubMed ID: 11467646
[TBL] [Abstract][Full Text] [Related]
38. Nutritional determinants of plasma total homocysteine distribution in the Canary Islands.
Henríquez P; Doreste J; Deulofeu R; Fiuza MD; Serra-Majem L
Eur J Clin Nutr; 2007 Jan; 61(1):111-8. PubMed ID: 16885934
[TBL] [Abstract][Full Text] [Related]
39. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
[TBL] [Abstract][Full Text] [Related]
40. A controlled trial of homocysteine lowering and cognitive performance.
McMahon JA; Green TJ; Skeaff CM; Knight RG; Mann JI; Williams SM
N Engl J Med; 2006 Jun; 354(26):2764-72. PubMed ID: 16807413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
